ABSTRACT MARTIN, WILLIAM J. (University of Utah, Salt Lake City), AND STANLEY MARcuS. Detoxified bacterial endotoxins. I. Preparation and biological properties of an acetylated crude endotoxin from Salmonella typhimurium. J. Bacteriol. 91:1453Bacteriol. 91: -1459Bacteriol. 91: . 1966.-Acetylation of a crude endotoxin prepared by the Roschka-Edwards (RE) procedure from a strain of Salmonella typhimurium yields a product with reduced pyrogenicity in rabbits as well as one which is nontoxic in mice. A reduction in pyrogenicity of approximately 100 times was noted with this acetylated crude endotoxin when compared with the parent RE preparation. A comparison was made of immunogenicity with mice of Boivin, RE, and acetylated Roschka-Edwards (Acet-RE) preparations with a heat-killed, phenol-preserved (HP) vaccine prepared from the same strain of S. typhimurium. Less than pyrogenic doses of all vaccines were not protective. The least pyrogenic preparation (Acet-RE) was immunogenically effective in about five times the minimal pyrogenic dose. The data suggest that the Acet-RE preparation should be considered further in the search for enteric fever vaccines with lowered potential for undesirable systemic responses.
The toxicity of available vaccines against Salmonella typhosa and other enterobacteriaceal organisms is a problem, particularly for international travelers and for those under military conditions, where the loss in personnel time due to immunization reactions may be significant. Attempts to provide protection against salmonellae and Salmonella-like enteric diseases with polyvalent vaccines must also take into account the additive nature of the toxicities of the component organisms. A procedure that would minimize side reactions would be to reduce the amount of each component until the toxicity of the individual components was within tolerable limits. Since the antigenic potential of a bacterial vaccine is influenced by concentration of bacteria, however, this procedure might result in use of less than immunogenic concentrations of vaccine. In recent years, the procedure of chemically modifying the endotoxin molecule by acetylation with recovery of a preparation showing reduced pyrogenicity and lethality without the apparent destruction of immunogenicity has been reported by Treffers (13) , Treffers et al. (Federation Proc. 5:255, 1946) , and Freedman and his associates (2, 3, 12) . In this paper we describe the acetylation of a crude endotoxin material obtained by the Roschka-Edwards (RE) method from a strain of Salmonella typhimurium. Results indicate that the preparation obtained had reduced pyrogenicity in rabbits, although no apparent reduction in mouse lethality was observed when compared with the parent RE preparation. In addition, data are shown concerning immunogenicity in mice of a Boivin vaccine preparation, a RE vaccine preparation, and the acetylated RE vaccine preparation compared with a heat-killed, phenol-preserved vaccine prepared from the same strain of S. typhimurium. The hypothesis examined is that a nonpyrogenic, nontoxic product may still retain its immunogenicity, i.e., act as an "endotoxoid." An ultimate objective of such work is to use this product as a less toxic enteric fever vaccine.
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MATERIALS AND METHODS Experimental animals. Testing for pyrogenicity was done in rabbits (albino Oryctolagus cuniculus) that had been properly "screened" by methods previously reported (6) . In brief, previously sham-tested male and female rabbits (3 to 5 kg) obtained from a local source were caged individually in a constant-temperature room. Pyrogen tests were carried out according to techniques described in The United States Pharmacopeia XVI, with the following exceptions: all glassware was boiled in detergent solution, then rinsed with nonpyrogenic distilled water, and sterilized by heating in an oven at 250 C for 2 hr. Pyrogen-free (PF) saline solutions to be tested were at room temperature rather than at 37 C; total volumes of PF saline solutions injected were 33 ml per rabbit instead of the usual 10 ml/kg of rabbit weight; temperature recordings were taken at 1 hr and immediately prior to injection, and at 15 min, 1, 2, and 3 hr after injection. The results were interpreted as per The United States Pharmacopeia XVI. Rabbits which yielded positive fever results, and which were used in more than one experiment involving pyrogenicity, were "rested" for at least 2 weeks before being reused.
In each experiment, one group of rabbits injected with PF saline was included. This group served as a control for technique and other external factors such as temperature, humidity, and noise.
Mice. Tests for immunogenicity and lethality were performed in the morning with white mice (albino Mus musculus) weighing approximately 20 to 25 g; deaths were recorded for a period of 1 week.
Organism employed. A mouse-virulent strain of S. typhimurium was employed in all experiments and was originally obtained from the Utah State Department of Health. This organism has been maintained by transfer culture at monthly intervals on nutrient agar slants. Transfers were incubated at 37 C for 24 hr and were thereafter kept at room temperature.
Preparations for the REprocedure. Crude endotoxin was prepared according to the procedure of Edwards (1), which is primarily an alcohol-acetone treatment of bacterial cells. The sediment was dried at 37 C and then ground to a fine powder. The resulting dried powder, consisting primarily of the "hulls" of these Salmonella organisms, was further disintegrated by the use of an ultrasonic disintegrating device. A 15-ml amount of water was added to 1,500 mg of this crude endotoxin and was disintegrated (Sonifier, Branson Instruments, Stamford, Conn.) for 15 min under sterile conditions. The suspension was then filtered and the precipitate was dried overnight at 37 C. This procedure of ultrasonic exposure produced no visible changes in yield or in alteration of the crude endotoxin. Hereafter, this product will be referred to as the parent RE preparation.
Preparations for acetylation procedure (2) . To 500 mg of parent RE preparation were added 115 ml of acetic anhydride and 75 mg of anhydrous powdered sodium acetate as a basic catalyst. The reaction mixture was heated in a capped centrifuge bottle in a boiling-water bath for 4 hr with occasional mixing. After cooling, the acetic anhydride was removed as a Hereafter, this product will be referred to as the acetylated Roschka-Edwards (Acet-RE) preparation. Attempts to recover an anhydride-soluble, waterinsoluble material by pouring the anhydride solution into excess cold water and filtering it yielded a small amount of solids which accounted for less than 10% of our starting material. Since the yield was small, no attempt was made to test its biological effects in animals.
In all procedures, precautions to avoid contamination by extraneous pyrogens were rigorously observed. All glassware and other apparatus were heated at 250 C for 2 hr before use, and saline and distilled water were prepared to be pyrogen-free (PF) (6) .
Boivin preparation. Lipopolysaccharide extracted by trichloroacetic acid from a strain of S. typhimurium was used as the source of "pure" endotoxin (Difco).
Heat-killed, phenol-preserved (HP) vaccine. A freshly prepared heat-killed, phenol-preserved (HP) vaccine of S. typhimurium was prepared in the following manner. Cultures (18 hr) of S. typhimurium, grown on tryptose-phosphate (Difco) agar, were harvested in saline. After the suspension was filtered through sterile glass wool, the organisms were heated in a 56 C water bath for 2 hr. After heating, the suspension was cooled to room temperature, and was standardized turbidimetrically by the McFarland method (4). Dilutions were prepared in PF saline to give a final concentration of 1.8 X 101 organisms per milliliter (McFarland S 6) of saline containing 0.5% phenol. The vaccine was then put in sterile vials, fitted with the appropriate sterile rubber stoppers, and stored in a refrigerator until ready for use.
Method of challenge. The potency of the vaccines was, for the most part, determined by active-immunized mouse-protection tests as outlined by the Public Health Service, Division of Biologics Standards (8) . In each test, groups of 20 mice were immunized Lethality of Acet-RE, RE, and Boivin preparations injected intraperitoneally into mice. In Table  2 are shown the data from experiments compar- ing the lethality by ip injection of a pool of five individual acetylated preparations with that of the parent RE "crude" endotoxin preparations and "pure" endotoxin (Boivin), respectively. However, the saline control mice show mortalities of greater than 90% in the same 3-day period, thus indicating good agreement with the estimate of a 10 LD50 response. It is of interest to note that, after 3 days, the cumulative deaths of the immunized mice challenged with 10 LD5o showed a marked increase on the 4th day, whereas the immunized mice challenged with a LD50 were protected up through the 6th day.
Immunogenic effect of Acet-RE, RE, Boivin, and HP vaccine preparations in mice against a 10 LD5o challenge of S. typhimurium. Since it was found (Table 3) that the 10 LD5o challenge gave a reproducible end point within the 3-day observation period, it was decided to employ this dose for all challenge experiments involving the various vaccine preparations. The data in the next two tables (Tables 4 and 5) show results of experiments with groups of mice immunized with the Acet-RE, RE, Boivin, saline, and HP vaccine preparations, respectively. Each animal received a total of 2 sc injections, the second 7 days after the first, with the amounts shown under the column headed Immunizing dose. The immunizing doses of 100 and 200 ,ug/0.5 ml for the various preparations shown in both tables were arbitrarily arrived at, since < 200 ,ug of the Acet-RE preparation was found to be nonpyrogenic in rabbits. By again employing the DBS criteria of recording deaths over a 3-day period, the HP vaccine provided the best protection when compared with the respective saline control mice as well as with the mice immunized with 100-,ug dose amounts. Of the latter, as shown in Table 4 , the mice immunized with the Boivin preparation show the greatest protection, followed by the RE and Acet-RE vaccine preparations, respectively. The data presented in Table 4 and data from other active-immunized mouse protection experiments employing the MPD of 100 Mg were essentially the same. However, as shown in Table 5 , the deaths recorded over a 3-day period in mice immunized with two 200-,ug (two times the MPD) doses with the same Acet-RE vaccine preparation indicate a good minimal immunogenic dose (MID) when compared with the saline-immunized mice after challenge. Moreover, these results correlated well with the results obtained with the HP vaccine-immunized mice challenged with the same 10 LDBo. That is, the HP vaccine protected 90% of the mice as compared with 65% protection in the 200 Mug (Acet-RE)-immunized mice.
Further evidence of this correlation between the Acet-RE and HP vaccine preparations was shown by chi-square analysis (5) . Although both of these preparations show significant protection at the 1 % level when compared with the saline control group after 3 days, the difference in mouse protection between the Acet-RE and HP vaccine preparations was not significant (HP: > .05). Thus, under the conditions of these experiments, the 200-,ug immunizing dose of the Acet-RE vaccine preparation, but not the 100-,ug dose, yielded results not significantly different from those obtained with HP vaccine.
Immunogenic effect with two, weekly S00-,ug immunizing doses (total 1,000 ,ug) of the Acet-RE vaccine preparation in mice against a 10 LDs0 challenge of S. typhimurium. Since all previous results, including results not reported here, indicated that the HP vaccine is more protective in mice against a 10 LD5o challenge than the 100-;Lg Acet-RE immunizing dose employed (Table 4) , the hypothesis was examined that the Acet-RE vaccine preparation is not as immunogenic as the HP vaccine. That is, rather than relying on the approximate MPD of the Acet-RE preparation as the MID to employ in mouse-immunization experiments, the following considerations suggested other possibilities. Approximately 1 mg of wet bacteria contains 109 bacterial cells (10) or approximately 200 ,g of solids (dry weight). The HP vaccine employed in our active mouse-immunization experiment contains approximately 900 X 106 bacteria per 0.5 ml. This value suggested that our mice were receiving anywhere from 200 to 500 ,ug per immunizing dose of HP vaccine. The Acet-RE preparations had been used only in 100 and 200 ,g/0.5 ml immunizing doses, since the MPD of this preparation is approximately 100 Mg. Thus, we may have been administering two to five times more of the HP vaccine than of the Acet-RE preparation. This possibility was tested experimentally (Table 6 ).
Animals injected with 500-,pg immunizing doses of the Acet-RE vaccine preparation were compared with mice similarly injected (twice) with HP vaccine; the results support the hypothesis that there is a factor of approximately 2 to 5 in vaccine strength between the two vaccines. That is, no significant difference in mouse mortality either at the 3-day or 7-day observation period occurs. These data suggest that the difference between the MPD (100 Mg) and the MID (200 Mug), as well as the effective immunogenic dose (EID) (500 ,g), is approximately two to five in rabbits and mice, respectively. In other words, it takes approximately two to five times the MPD of the Acet-RE preparation to give an immunogenic dose equal to that of the HP vaccine.
DIscussIoN
It is apparent that acetylation of a crude endotoxin prepared by the RE procedure from a strain of S. typhimurium yielded a material which was nontoxic in mice and had a reduced fever effect in rabbits. That (2) . These investigators noted a marked reduction in pyrogenicity with their acetylated endotoxin (fraction P) of 1,000-fold and 100-fold, respectively. Thus, any real differences in rabbit pyrogenicity that do exist with the respective endotoxoids may be due, as previously mentioned, to the "purity" of the respective parent endotoxins.
Of interest is the finding that the mouse LDW of both the Acet-RE and the RE preparation was >2,500 ,ug, whereas Freedman and Sultzer (2) reported an LDW response in mice of 250 MAg with their parent endotoxin derived from S. typhosa, while acetylation of this same endotoxin yielded a mouse LD50 of approximately 2,000 pig. These observations lend support to the idea that the molecular site or sites of the RE preparation responsible for mouse lethality are apparently "masked." That is, under our experimental conditions, anywhere from 10 to 50 times more of the parent RE preparation (>2,500 Mug) is needed to produce the same LD5o response as those reported above for the Boivin endotoxin.
A critical evaluation of the immunogenicity of the vaccine preparations was obtained by employing the active-immunized mouse protection test. The reproducibility of the 10 LD60 challenge dose in each of the active mouse-protection tests has been remarkably consistent with these conditions of challenge. The saline control mice included in each experiment showed a reproducible 10 LD6o response within 72 hr after ip challenge with the test strain of S. typhimurium. Therefore, it was assumed that protection was dependent on the immunogen and the immunization schedule. Moreover, this was observed in mice with all of our endotoxoid preparations (Martin and Marcus, in 
